Press "Enter" to skip to content

Indian pharma sector expected to grow at 10-12 pc during FY19-22, outlook stable: Icra

It, however, said increased cost related to regulatory compliances, especially for the US market, price controls across markets and mandatory genericisation for Indian market remained key risks.

Original source: https://health.economictimes.indiatimes.com/news/pharma/indian-pharma-sector-expected-to-grow-at-10-12-pc-during-fy19-22-outlook-stable-icra/72869319?utm_source=RSS&utm_medium=ETRSS

Also Read:   Covid-19 outbreak: Pharma companies airlift inputs to deal with supply disruptions